Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia
Clinical trial NCT04390971 · COMPLETED
Trial details
- NCT number
- NCT04390971
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-10
- Primary completion
- 2023-03-05
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.